Therapeutic efficacy of a biosimilar epoetin alfa in hemodialysis patients

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia

Volumn 26, Issue 1, 2015, Pages 78-82

  Harzallah, Amel ^a   Zouaghi, Karim ^a   Dridi, Afef ^a   Boubaker, Karima ^a   Beji, Soumaya ^a   Ayari, Mohamed ^a   El Younsi, Fethi ^a   Moussa, Fatma B en ^a   Kheder, Adel ^a  

^a CHARLES NICOLLE HOSPITAL   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; BIOSIMILAR AGENT; ERYTHROPOIETIN; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT PROTEIN;

ADULT; AGED; ANEMIA; BLOOD; BLOOD PRESSURE; CLINICAL TRIAL; COMPLICATION; DRUG SUBSTITUTION; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; THERAPEUTIC EQUIVALENCE; TUNISIA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; BIOSIMILAR PHARMACEUTICALS; BLOOD PRESSURE; DRUG SUBSTITUTION; ERYTHROPOIETIN; FEMALE; HEMATINICS; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; THERAPEUTIC EQUIVALENCY; TUNISIA;

EID: 84925284764     PISSN: 13192442     EISSN: None     Source Type: Journal    
DOI: 10.4103/1319-2442.148744     Document Type: Article

References (0)